Breast cancer patients need to pay special attention to the use of drugs in the course of treatment and in daily life, as certain drugs may aggravate the condition or affect the effectiveness of treatment. The following drugs are not suitable for some breast cancer patients:
Drugs affecting the endocrine system
Polypanone: This drug may affect the endocrine system and contribute to increased levels of oxytocin, leading to the recurrence of breast cancer.
Methoxychloropamine: As a dopamine receptor blocker, it acts as a central hub that promotes oxylogenation and, in turn, increases mammograms and discourages breast cancer treatment.
3. Symmettin: This drug is resistant to male hormones, affects lipid metabolism and causes high oxytocinemia, etc., to the detriment of breast cancer patients.
4. Contraceptives: Because most of the components of the pill contain a large number of gestational and estrogens, the long-term use of the pill may lead to the recurrence and transfer of breast cancer, breast cancer should be avoided.
II. Anti-psychotic drugs
• chloropropazine: The oxytocin can be reduced by cutting the dopamine receptor and reducing the euphemism inhibition factor from the lower dope, thereby increasing the oxytocin, causing breast swelling and breast milk, which should be banned for breast cancer.
III. Antitensive drugs
• Prosemic: long-term use of this drug by menopausal women has the potential to increase the risk of breast cancer, which is three to four times higher than among older women who do not use it. There may also be a risk of a combination of formulations containing lysin, such as lysin, Andal, and equals in combination.
IV. Drugs related to breast cancer treatment (use with caution)
1. He is mosaic: While this drug is applied to early breast cancer patients who are hormonal positive after and before menopause, its long-term use requires regular monitoring of indicators such as hemophages, liver function and endomelet thickness and is banned for pregnant women.
The drugs are aromatic enzyme inhibitors and are used to assist patients with post-menopausal breast cancer. When used, care needs to be taken to observe indicators such as changes in bone density, liver function and blood resin levels and possible side effects such as tidal heat and headaches.
V. Other drugs for prudent use
• Chlorobrey: Anticondensation therapy for acute coronary syndrome that irreversibly inhibits blood plate accumulation and reduces the incidence of vascular obstruction. However, the risk of haemorrhage should be regularly assessed and condensed time monitored for use by breast cancer patients.
• Chemotherapy drugs, such as octanool, Dosipetha, cyclophosphodomide, fluorourexyl, and phosphate, which, while available for breast cancer treatment, may also have a lethal effect on normal cells and are used with close monitoring of the patient’s blood protocol, liver and kidney function, etc.
VI. LIFE ADVICE
In addition to avoiding the use of the above-mentioned drugs, the following should be noted in the daily life of breast cancer patients:
• Avoid the use of cosmetics, food and health care products containing sexual hormones.
• Maintain good living habits, stop smoking and alcohol, strengthen physical exercise and improve immunity.
• Periodic review to keep abreast of changes in the situation.
In general, patients with breast cancer should be particularly careful when using drugs that may aggravate the condition or affect the efficacy of treatment. The advice of a professional doctor or a pharmacist must be consulted before medicines are used.
